Journal of Public Health Policy

, Volume 28, Issue 4, pp 456–464 | Cite as

Control of Blinding Eye Diseases in Leprosy: Strategies for India

Article
First Online:
  • 8 Downloads

Abstract

Over half of the people affected by leprosy worldwide are in India, many of whom are severely disabled when they present for care. Changes in policy and the integration of the leprosy programme with general health services has given rise to new challenges for the control of blinding eye disease in leprosy patients. This paper looks at the challenges posed: management, materials, manpower, money, and mobility – all of which are common barriers to the availability, access, and utilization of services – and to monitoring existing programmes. We consider strategies to overcome these challenges and fulfill the goal of VISION 2020 – eliminating avoidable blindness – through the provision of comprehensive eye care and strengthening the existing infrastructure. Formal cooperation between national governments, non-governmental organisations, and International Development Agencies will need to continue, although possibly, in different roles and with plans modified to be relevant to the local needs of leprosy patients.

Keywords

vision 2020 blindness control leprosy disability 
This is a preview of subscription content, log in to check access.

References

  1. World Health Organization. Weekly Epidemiological Report No. 34. Global leprosy Situation, 2005. Geneva; 2005.Google Scholar
  2. Courtright P, Lewallen S . The Epidemiology of Eye Disease. Arnold: London; 2003.Google Scholar
  3. Ffytche TJ . The prevalence of disabling ocular complications of leprosy: a global study. Indian J Lepr. 1998;70(1):49–59.Google Scholar
  4. Courtright P, Daniel E, Sundarrao, Ravanes J, Mengistu F, Belachew M, Celloria RV, Ffytche T . Eye disease in multibacillary leprosy patients at the time of their leprosy diagnosis: findings from the Longitudinal Study of Ocular Leprosy (LOSOL) in India, the Philippines and Ethiopia. Lepr Rev. 2002;73(3):225–238.Google Scholar
  5. Hogeweg M . Cataract: the main cause of blindness in leprosy. Lepr Rev. 2001;72(2):139–142.Google Scholar
  6. Courtright P, Lewallen S, Tungpakorn N, Cho BH, Lim YK, Lee HJ, Kim SH . Cataract in leprosy patients: cataract surgical coverage, barriers to acceptance of surgery, and outcome of surgery in a population based survey in Korea. Br J Ophthalmol. 2001;85(6):643–647.CrossRefGoogle Scholar
  7. Mpyet C, Dineen BP, Solomon AW . Cataract surgical coverage and barriers to uptake of cataract surgery in leprosy villages of north eastern Nigeria. Br J Ophthalmol. 2005;89(8):936–938.CrossRefGoogle Scholar
  8. Courtright P, Lewallen S . Current concepts in the surgical management of lagophthalmos in leprosy. Lepr Rev. 1995;66(3):220–223.Google Scholar
  9. WHO/TDR. TDR News: Integrating Leprosy Control: New Challenges for Implementation Research. Geneva: World Health Organization; 2004. Available at http://www.who.int/tdr/publications/trdnews/news72/leprosy_control.htm, accessed 11/03/2005.
  10. Hogeweg M, Keunen JE . Prevention of blindness in leprosy and the role of the Vision 2020 Programme. Eye. 2005;19(10):1099–1105.CrossRefGoogle Scholar
  11. Courtright P . Summary of the Symposium on Prevention of Blindness in Leprosy in Africa: 2005 February 1st, KCCO, Tanzania. Available at http://www.kero.net/preventionofblindnessinleprosyinAfrica.pdf, accessed 10/04/2006.

Copyright information

© Palgrave Macmillan Ltd 2007

Authors and Affiliations

  1. 1.Aravind Eye Care SystemMaduraiIndia

Personalised recommendations